Skip to main content
SYBX
OTC Life Sciences

Synlogic Q3 10-Q: $11.6M Cash, Material Weakness Persists Ahead of Caldera Merger

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.03
Mkt Cap
$12.616M
52W Low
$0.54
52W High
$1.87
52W Position info
91% above low
Off High info
45% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

SYBX sits 91% above its 52-week low of $0.54 on light trading volume (0.3× avg).

Summary

Synlogic's Q3 10-Q shows cash down to $11.6 million, with $3.1 million used in operations over nine months and merger-related charges of $2.0 million. A material weakness in internal controls remains unremediated as the Caldera merger awaits stockholder approval.


Key Events · Earnings and Guidance · SYBX

  • Cash Falls to $11.6 Million

    Cash and cash equivalents stood at $11.6 million on September 30, 2026, down from $14.7 million at December 31, 2025, as $3.1 million went to operating activities over the nine months.

  • Merger Costs Drive Charges

    Restructuring and transaction related charges reached $2.0 million for the nine months ended September 30, 2026, versus $0.2 million a year earlier, driven by legal and professional fees tied to the Merger Agreement; $1.1 million remained unpaid in accrued expenses.

  • Material Weakness Still Unremediated

    Management said the previously disclosed material weakness in internal control over financial reporting continues to be present as of September 30, 2026, and that disclosure controls and procedures were not effective.

  • Warrant Remeasurement Is Non-Cash

    The July 27, 2026 warrant amendment moved the purchase warrants to equity, producing a $1.7 million non-cash remeasurement loss in Q3 and a $0.5 million gain for the nine months; no purchase warrants have been exercised.


Analysis · SYBX · Life Sciences

With Synlogic now a one-employee public shell awaiting its merger with Caldera Therapeutics, this 10-Q lays out the cost of that wait. Cash fell to $11.6 million from $14.7 million at year-end, with $3.1 million burned in nine months, while restructuring and transaction charges tied to the merger reached $2.0 million. Management says its cash funds operations for at least 12 months, but the previously disclosed material weakness in internal controls remains unremediated and disclosure controls were again deemed not effective. The merger terms are unchanged: Synlogic holders are set to own roughly 2.3% of the combined company, Caldera holders 62.8%, and a $278.0 million concurrent financing 34.9%, subject to stockholder votes and an effective Form S-4.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SYBX was trading at $1.03 on OTC in the Life Sciences sector, with a market capitalization of approximately $12.6M. The 52-week trading range was $0.54 to $1.87. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SYBX - Latest Insights

SYBX
Nov 05, 2026, 8:54 AM EST
Filing Type: 425
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $1.10 info
Change: +$0.100 (+10%) info
Market Cap: $13.474M info
SYBX
Aug 11, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $1.10 info
Change: -$0.080 (-7%) info
Market Cap: $13.474M info
SYBX
Jul 29, 2026, 7:40 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $1.10 info
Change: -$0.020 (-2%) info
Market Cap: $13.474M info
SYBX
Jul 29, 2026, 4:18 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $1.10 info
Change: -$0.020 (-2%) info
Market Cap: $13.474M info
SYBX
Jul 29, 2026, 7:19 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.720
Real-time Price: $1.10 info
Change: +$0.380 (+53%) info
Market Cap: $13.474M info